Adjuvant chemotherapy versus NEOadjuvant gemcitabine/ oxaliplatin plus adjuvant gemcitabine in resectable PAncreatic Cancer: a randomized multicenter phase III study

Registry ID

EUCTR2010-021477-36

Source registry

EUCTR

Status

Completed

Phase

PHASE3

Sponsor

Gesellschaft für Studienmanagement und Onkologie mbH

Start date

2014-12-30

Completion date

2017-12-15

Last update

2026-08-16

Conditions

• resectable pancreatic cancer

Summary

The aim of the study is to test the additional value of neoadjuvant chemotherapy to the standard treatment for resectable pancreatic cancer (surgery + adjuvant chemotherapy) by comparing progression-free survival (PFS)

Locations

• , , Germany
• , , Belgium

View on source registry